A detailed history of Maven Securities LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Maven Securities LTD holds 67,856 shares of BMY stock, worth $3.93 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
67,856
Previous 67,856 -0.0%
Holding current value
$3.93 Million
Previous $2.82 Million 24.59%
% of portfolio
0.45%
Previous 0.48%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $3.26 Million - $3.69 Million
67,856 New
67,856 $3.68 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $3,348 - $1.98 Million
25,756 New
25,756 $18.3 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $302,297 - $362,481
-4,917 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $148,715 - $173,367
2,773 Added 129.34%
4,917 $307,000
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $346,499 - $405,879
-5,856 Reduced 73.2%
2,144 $127,000
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $495,280 - $539,360
8,000 New
8,000 $535,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.